What does NV R.E.D. LABORATORIES do?

NV R.E.D. LABORATORIES is a healthcare practice in Asse. Public Limited, started on 12 February 1998, 1 establishment.

What is the address of NV R.E.D. LABORATORIES?

The registered office of NV R.E.D. LABORATORIES is located at Z. 1 Researchpark 100, 1731 Asse.

Is NV R.E.D. LABORATORIES still active?

Yes. According to the CBE (30 October 2026) NV R.E.D. LABORATORIES is active, legal situation “Normale toestand”, started on 12 February 1998.

Is NV R.E.D. LABORATORIES registered on Peppol?

Yes, NV R.E.D. LABORATORIES is registered on the Peppol network with ID 0208:0462648824.

What is the enterprise number of NV R.E.D. LABORATORIES?

The enterprise number of NV R.E.D. LABORATORIES is BE0462648824.

When was NV R.E.D. LABORATORIES founded?

NV R.E.D. LABORATORIES was founded on 12 February 1998.

Who are the directors of NV R.E.D. LABORATORIES?

According to the 2025 annual accounts, the directors of NV R.E.D. LABORATORIES are: Louis TEULIÈRES.

Is NV R.E.D. LABORATORIES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 February 1998; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NV R.E.D. LABORATORIES make in 2025?

NV R.E.D. LABORATORIES recorded a loss after taxes of € 64,757 in financial year 2025.

What is the revenue of NV R.E.D. LABORATORIES?

As a small company, NV R.E.D. LABORATORIES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 859,641.

How much does an employee at NV R.E.D. LABORATORIES earn?

The average wage cost per full-time employee at NV R.E.D. LABORATORIES was € 103,000 in 2025: staff costs of € 710,448 for 6.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does NV R.E.D. LABORATORIES have?

According to the 2025 annual accounts, NV R.E.D. LABORATORIES has 6.9 full-time equivalents (FTE).

NV R.E.D. LABORATORIES (Public Limited) - Asse

Dossier NV R.E.D. LABORATORIES, printed on 30 October 2026 from databakkes.be/en/0462648824/nv-r-e-d-laboratories. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

NV R.E.D. LABORATORIES from Asse, company number BE0462648824, closed financial year 2025 with a result of € -64,757 after tax. For that financial year NV R.E.D. LABORATORIES recorded a gross margin of € 859,641 and equity of € 2.4 million. Compared with financial year 2024, the result moved from € -102,193 to € -64,757. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Healthy

€ 2.4 million

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -64,757

▲ 37 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71,058

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 50,352.

People and assets in 2025

Full-time equivalents

6.9

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 710,448

▲ 17% vs 2024

€ 103,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 298,688

▼ 13% vs 2024

Of which on lease € 278,046.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 177,142

▼ 9% vs 2024

€ 13,467 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 206,100

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 76,865

▲ 1% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 625,576 Gross margin 2022: € 625,576 First fiscal year in the series	€ 737,808 Gross margin 2023: € 737,808 ▲ 18% vs 2022 (€ 625,576) Favourable step	€ 736,867 Gross margin 2024: € 736,867 Unchanged (€ 737,808) Unfavourable step	€ 859,641 Gross margin 2025: € 859,641 ▲ 17% vs 2024 (€ 736,867) Favourable step	▲ 17%
Profit after taxes	€ -236,307 Profit after taxes 2022: € -236,307 First fiscal year in the series	€ -434,094 Profit after taxes 2023: € -434,094 ▼ € 197,787 vs 2022 (€ -236,307) Unfavourable step	€ -102,193 Profit after taxes 2024: € -102,193 ▲ € 331,901 vs 2023 (€ -434,094) Favourable step	€ -64,757 Profit after taxes 2025: € -64,757 ▲ € 37,436 vs 2024 (€ -102,193) Favourable step	▲ € 37,436
Equity	€ 2,974,643 Equity 2022: € 2,974,643 First fiscal year in the series	€ 2,540,549 Equity 2023: € 2,540,549 ▼ 15% vs 2022 (€ 2,974,643) Unfavourable step	€ 2,438,356 Equity 2024: € 2,438,356 ▼ 4% vs 2023 (€ 2,540,549) Unfavourable step	€ 2,373,599 Equity 2025: € 2,373,599 ▼ 3% vs 2024 (€ 2,438,356) Unfavourable step	▼ 3%
Total debts	€ 382,602 Total debts 2022: € 382,602 First fiscal year in the series	€ 326,718 Total debts 2023: € 326,718 ▼ 15% vs 2022 (€ 382,602) Favourable step	€ 427,143 Total debts 2024: € 427,143 ▲ 31% vs 2023 (€ 326,718) Unfavourable step	€ 460,107 Total debts 2025: € 460,107 ▲ 8% vs 2024 (€ 427,143) Unfavourable step	▲ 8%
Cash	€ 103,927 Cash 2022: € 103,927 First fiscal year in the series	€ 72,900 Cash 2023: € 72,900 ▼ 30% vs 2022 (€ 103,927) Unfavourable step	€ 104,243 Cash 2024: € 104,243 ▲ 43% vs 2023 (€ 72,900) Favourable step	€ 71,058 Cash 2025: € 71,058 ▼ 32% vs 2024 (€ 104,243) Unfavourable step	▼ 32%
Retained profit	€ 651,395 Retained profit 2022: € 651,395 First fiscal year in the series	€ 217,301 Retained profit 2023: € 217,301 ▼ 67% vs 2022 (€ 651,395) Unfavourable step	€ 115,108 Retained profit 2024: € 115,108 ▼ 47% vs 2023 (€ 217,301) Unfavourable step	€ 50,352 Retained profit 2025: € 50,352 ▼ 56% vs 2024 (€ 115,108) Unfavourable step	▼ 56%
Bank debt	€ 134,475 Bank debt 2022: € 134,475 First fiscal year in the series	€ 97,029 Bank debt 2023: € 97,029 ▼ 28% vs 2022 (€ 134,475) Favourable step	€ 195,357 Bank debt 2024: € 195,357 ▲ 101% vs 2023 (€ 97,029) Unfavourable step	€ 177,142 Bank debt 2025: € 177,142 ▼ 9% vs 2024 (€ 195,357) Favourable step	▼ 9%
Balance sheet total	€ 3,357,245 Balance sheet total 2022: € 3,357,245 First fiscal year in the series	€ 2,867,268 Balance sheet total 2023: € 2,867,268 ▼ 15% vs 2022 (€ 3,357,245) Unchanged	€ 2,865,499 Balance sheet total 2024: € 2,865,499 Unchanged (€ 2,867,268) Unchanged	€ 2,833,706 Balance sheet total 2025: € 2,833,706 ▼ 1% vs 2024 (€ 2,865,499) Unchanged	▼ 1%
Employees (FTE)	7.5 Employees (FTE) 2022: 7.5 First fiscal year in the series	6.2 Employees (FTE) 2023: 6.2 ▼ 1.3 vs 2022 (7.5) Unchanged	6.3 Employees (FTE) 2024: 6.3 ▲ 0.1 vs 2023 (6.2) Unchanged	6.9 Employees (FTE) 2025: 6.9 ▲ 0.6 vs 2024 (6.3) Unchanged	▲ 0.6

Key figures of NV R.E.D. LABORATORIES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NV R.E.D. LABORATORIES?

What happened at NV R.E.D. LABORATORIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: loss of € 64,757. Source: NBB ↗
2025 Louis TEULIÈRES became a director. NBB
May 20, 1998 New establishment in Asse. KBO
Feb 12, 1998 Start of the company according to the CBE. KBO

In short

From € 236,307 loss in 2022 to € 64,757 loss in 2025.

Paid € 5,164 in corporate taxes since 2022.

On average € 124,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BIORED 65.6%

The stake of BIORED comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

NV R.E.D. LABORATORIES

REDRENO LLC 100%

PROTEA BIOPHARMA 100%

Behind NV R.E.D. LABORATORIES is Louis TEULIÈRES. The shares are held by BIORED (65.6%). It owns 100% of REDRENO LLC and 100% of PROTEA BIOPHARMA itself.

Directors

According to the 2025 annual accounts

Louis TEULIÈRES

Managing director

since 2025

Shareholders

BIORED

65.6%

Participations

REDRENO LLC

100%

PROTEA BIOPHARMA

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Z. 1 Researchpark 100

1731 Asse

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0462.648.824

VAT number

BE 0462.648.824

Registered office

Z. 1 Researchpark 100, 1731 Asse

Names & denominations

NV R.E.D. LABORATORIES

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

12 February 1998

Peppol

Active · Active since 25 Jul 2025

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Overige technische testen en toetsen

Technische testen en analyses

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

NV R.E.D. LABORATORIES

Warning lights

Financials

What happened to NV R.E.D. LABORATORIES?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions